Related Experiment Videos
Theoretical bases for vascular selectivity of Ca2+ antagonists
Journal of Cardiovascular Pharmacology
|January 1, 1984
Summary
Calcium antagonists selectively inhibit distinct calcium channels in vascular tissues, clarifying their mechanism of action and therapeutic selectivity. These findings advance our understanding of vascular smooth muscle activation and drug targeting.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Molecular Biology
Background:
- Vascular smooth muscle contraction is regulated by calcium (Ca2+) influx.
- Calcium antagonists (CAt) are used to treat cardiovascular diseases.
- The precise mechanisms of CAt selectivity remain incompletely understood.
Purpose of the Study:
- To characterize vascular tissue activation mechanisms.
- To elucidate theoretical bases for calcium antagonist (CAt) selectivity.
- To differentiate receptor-operated (ROC) and potential-operated (POC) calcium channels.
Main Methods:
- Studied rabbit aorta, mesenteric artery, and resistance vessels.
- Measured isometric contractions, 45Ca fluxes, and intracellular membrane potentials.
- Utilized agonists (norepinephrine) and depolarizing potassium (K+) solutions, and CAt (D-600, diltiazem, nisoldipine).
Main Results:
- CAt inhibited K+-induced Ca2+ influx and contractions, indicating Ca2+ entry inhibition.
- Norepinephrine (NE) and 80 mM K+ activated distinct Ca2+ channels (ROC and POC).
- Evidence included additive effects of NE and K+ on Ca2+ influx and differential CAt inhibition of ROC/POC.
Conclusions:
- Calcium antagonists primarily inhibit Ca2+ entry through potential-operated channels (POC).
- Norepinephrine and K+ activate distinct Ca2+ channels (ROC and POC, respectively).
- CAt exhibit varying selectivity for ROC versus POC in different vascular beds.